SCHEMBL24361197

SCHEMBL24361197

O=C(OC1CCCCC1)c1cc(I)ccc1OC(F)(F)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN8A Q9UQD0 2/20 0.38
▸ SCN10A Q9Y5Y9 2/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ NOTUM Q6P988 1/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ MMP9 P14780 2/20 0.34
▸ MMP12 P39900 2/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ STS P08842 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ GPR35 Q9HC97 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24361404 0.84 KMT2A (0.45) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL23518947 0.78 NOTUM (0.53) KMT2ARAB9ANOTUMSMN1; SMN2MAPT
SCHEMBL23518950 0.78 NOTUM (0.41) NOTUMUSP2ALDH1A1HPGDHSD17B10
SCHEMBL23518973 0.75 NOTUM (0.38) NOTUM
SCHEMBL23518968 0.75 GABRA1 (0.42) MEN1KMT2ARAB9ANPC1NOTUM
SCHEMBL26206418 0.74 MEN1 (0.36) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL23518946 0.72 STS (0.56) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL828645 0.69 NPC1 (0.54) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL23519122 0.68 SERPINE1 (0.35) —
SCHEMBL23519131 0.67 SLC6A4 (0.42) RAB9ANPC1NOTUMMAPTPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS CACNA1F, SLC6A5, IDUA SCN8A 2040/4885SCN10A 874/4885MEN1 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback